J&J Fights Cherokee Bid To Move Risperdal Lawsuit
By Hannah Sheehan ( February 2, 2016, 12:11 AM EST) -- Johnson & Johnson and subsidiary Janssen Pharmaceuticals told an Oklahoma federal judge Monday that a holding company for tribal businesses and not the tribe itself is the rightful plaintiff in the Cherokee Nation's suit over the undisclosed side effects of Janssen's anti-psychotic drug Risperdal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.